We are thrilled to announce that TheraB Medical Inc has successfully raised $3,000,000 in funding to further our mission of revolutionizing jaundice treatment for newborns. TheraB Medical is dedicated to creating innovative medical devices that not only address critical health concerns but also prioritize emotional well-being through maternal-infant bonding. Our flagship product, SnugLit, is a groundbreaking portable, wearable phototherapy garment designed to allow mothers to hold and breastfeed their babies while undergoing treatment for jaundice. This unique approach promotes a holistic treatment experience by ensuring that the vital connection between mother and child is maintained, even during medical interventions.
With this new funding, TheraB Medical aims to accelerate the commercialization of SnugLit in the US and India, where jaundice affects a significant number of newborns. We have already collaborated with over 300 nurses and mothers to refine SnugLit, ensuring that it meets the needs of families while adhering to the highest safety and quality standards. The funds will be used to enhance our production capabilities, expand our marketing efforts, and facilitate our entry into key healthcare markets. We believe that every baby deserves the best start in life, and with the support of our investors, we are one step closer to making SnugLit a household name in neonatal care. Join us on this journey as we strive to transform the treatment landscape for jaundice and create a brighter future for mother and child.
